Literature DB >> 8077620

Management of peritoneal hemorrhage due to follicle rupture under anticoagulation therapy.

U Ulrich1, W G Rossmanith.   

Abstract

Severe bleeding into the peritoneal cavity from a ruptured ovulatory follicle is a rare complication in women receiving anticoagulation therapy. A number of both surgical and non surgical methods have been proposed to solve this problem. We adopted a novel therapeutic approach in a 40-year old patient who presented with recurrent acute hemoperitoneum under anticoagulation therapy for combined cardiac valve disease. The hemoperitoneum was successfully managed twice by laparoscopy. The patient then received intranasal GnRH analogue treatment together with transdermal estradiol and oral medroxyprogesterone-acetate. In this way ovarian sex steroids were replaced while cessation of ovarian function was achieved by the hypogonadotrophic condition. At the end of this mode of treatment no recurrence of a hemoperitoneum was seen in our patient. We therefore suggest that considerable gains may be expected from this method for the management of recurrent acute peritoneal hemorrhage caused by ovulation bleeding in patients under anticoagulation therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077620     DOI: 10.1007/BF03348998

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  8 in total

1.  Pregnancy in women with different types of von Willebrand disease.

Authors:  M Conti; D Mari; E Conti; M L Muggiasca; P M Mannucci
Journal:  Obstet Gynecol       Date:  1986-08       Impact factor: 7.661

2.  Conjugated estrogens for the management of bleeding associated with renal failure.

Authors:  M Livio; P M Mannucci; G Viganò; G Mingardi; R Lombardi; G Mecca; G Remuzzi
Journal:  N Engl J Med       Date:  1986-09-18       Impact factor: 91.245

Review 3.  Hemoperitoneum complicating chronic peritoneal dialysis: single-center experience and literature review.

Authors:  A Greenberg; J Bernardini; B M Piraino; J R Johnston; J A Perlmutter
Journal:  Am J Kidney Dis       Date:  1992-03       Impact factor: 8.860

4.  Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.

Authors:  R L Barbieri
Journal:  Am J Obstet Gynecol       Date:  1990-02       Impact factor: 8.661

5.  Recurrent hemoperitoneum in women receiving continuous ambulatory peritoneal dialysis.

Authors:  J D Harnett; D Gill; L Corbett; P S Parfrey; H Gault
Journal:  Ann Intern Med       Date:  1987-09       Impact factor: 25.391

6.  Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports.

Authors:  E Bottini; F I Pareti; D Mari; P M Mannucci; M L Muggiasca; M Conti
Journal:  Haematologica       Date:  1991 Sep-Oct       Impact factor: 9.941

Review 7.  Inhibition of ovulation: comparison between the mechanism of action of steroids and GnRH analogues.

Authors:  P Bouchard; J P Wolf; S Hajri
Journal:  Hum Reprod       Date:  1988-05       Impact factor: 6.918

8.  Rupture of ovarian cyst: massive hemoperitoneum in continuous ambulatory peritoneal dialysis patients: diagnosis and treatment.

Authors:  D S Fraley; J R Johnston; F J Bruns; S Adler; D P Segel
Journal:  Am J Kidney Dis       Date:  1988-07       Impact factor: 8.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.